Guardant Health (GH) Return on Capital Employed (2018 - 2026)

Guardant Health has disclosed Return on Capital Employed across 9 years of filings, most recently posting 26.76% for Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 26.76%, up 1150.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 26.76% (up 1150.0% YoY), and the FY2025 annual result was 30.22%, up 123.0% from the prior year.
• Return on Capital Employed came in at 26.76% for Q1 2026 at Guardant Health, up from 32.57% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 22.0% in Q1 2022 to a low of 41.9% in Q2 2025.
• The 5-year median for Return on Capital Employed is 35.14% (2024), against an average of 34.34%.
• Across the five-year window, Return on Capital Employed tumbled 1891 bps in 2023 and soared 1150 bps in 2026, its largest moves.
• Guardant Health's Return on Capital Employed stood at 37.22% in 2022, then increased by 4 bps to 35.61% in 2023, then rose by 3 bps to 34.48% in 2024, then rose by 6 bps to 32.57% in 2025, then advanced by 18 bps to 26.76% in 2026.
• The last three Return on Capital Employed figures came in at 26.76% (Q1 2026), 32.57% (Q4 2025), and 41.44% (Q3 2025), per Business Quant data.